Paper Details

  1. Home
  2. Paper Details

Cure of acute myelocytic leukemia in adults: a reality.

Author: BurkeP J, GellerR B, KarpJ E, SantosG W, SaralR

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study found similar cure rates for acute myeloid leukemia (AML) in adults using either bone marrow transplant or intensive chemotherapy. The study suggests that both approaches are effective, but further research is needed to determine the best treatment for individual patients.
Paper Details　
Original Abstract of the Article :
Adult acute myelocytic leukemia (AML) is a curable disease in responsive patients with aggressive treatment in remission. Over the past decade at the Johns Hopkins Oncology Center, AML has been treated with either allogeneic bone marrow transplantation or with intensive timed sequential treatment us...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2201825

データ提供：米国国立医学図書館（NLM）

Cure of acute myelocytic leukemia in adults: a reality

Acute myelocytic leukemia (AML) is a type of cancer that affects the blood and bone marrow. Researchers are constantly striving to find effective treatments for this challenging disease. This study explores the use of allogeneic bone marrow transplantation and intensive timed sequential treatment with high-dose cytarabine as potential cures for AML in adults.

Hope for Patients with AML: Promising Treatment Options

The study found that both allogeneic bone marrow transplantation and intensive timed sequential treatment with high-dose cytarabine resulted in comparable cure rates for responsive patients with AML. This is great news, offering hope for individuals battling this disease. While this research is encouraging, the authors emphasize the need for further studies to determine the most effective treatment for specific patients.

Navigating AML Treatment: A Collaborative Approach

The authors encourage collaboration between researchers, healthcare professionals, and patients to optimize treatment strategies for AML. This collaborative effort is crucial for improving patient outcomes and ensuring that all patients have access to the best possible care. It's important to remember that the journey through cancer treatment can be challenging, but with determination and support, hope for a cure can be found.

Dr. Camel's Conclusion

This study provides a beacon of hope for individuals battling acute myelocytic leukemia. The research underscores the importance of collaborative efforts between scientists, doctors, and patients in the fight against this challenging disease. By working together, we can continue to make progress in understanding and treating AML, bringing us closer to a future where this type of cancer is no longer a life-threatening threat.

Date :
  1. Date Completed 1990-09-21
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2201825

DOI: Digital Object Identifier

2201825

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.